Skip to main content
MESA LABORATORIES INC /CO/ logo

MESA LABORATORIES INC /CO/ - Investor Relations & Filings

Listed
Ticker · MLAB ISIN · US59064R1095 LEI · 549300ZCG738WLX8ZW79 US Manufacturing
Open in API
Filings indexed 1,019 across all filing types
Latest filing 2025-06-11 Director's Dealing
Country US United States of America
Listing US MLAB · 6 venues

About MESA LABORATORIES INC /CO/

https://mesalabs.com

Mesa Laboratories, Inc. designs, manufactures, and markets quality control products and services for regulated industries. The company specializes in life sciences tools and critical quality control solutions, including analytical instruments and related consumables. Its products are utilized primarily in the pharmaceutical, healthcare, and medical device sectors to ensure product safety, integrity, and performance. Mesa Laboratories focuses on applying technical expertise and technological innovation to help customers monitor and maintain high standards, supporting compliance with various regulatory requirements and international standards for quality management, testing, and calibration.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2025-06-11 English
PRIMARY DOCUMENT
Director's Dealing
2025-06-11 English
PRIMARY DOCUMENT
Director's Dealing
2025-06-11 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated June 3, 2025, reporting a change in the company's independent registered public accounting firm due to a merger of the prior auditor Moss Adams LLP with Baker Tilly US, LLP. It includes disclosures about the resignation of Moss Adams, appointment of Baker Tilly, and statements about audit opinions and disagreements. The document also references a letter from Moss Adams as an exhibit. There are no financial statements or substantive financial data included, only disclosures about auditor changes and related confirmations. This type of filing is a regulatory announcement about auditor changes and does not constitute a full audit report or annual report. According to the classification rules, such a document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit other specific categories like Audit Report or Annual Report. The document length (5519 characters) and content confirm it is not merely a report publication announcement but a substantive regulatory filing about auditor change.
2025-06-06 English
FORM 10-K
Annual Report FY 2025
2025-05-28 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 28, 2025, for Mesa Laboratories, Inc. It reports the issuance of a press release regarding the company's financial results for the three and twelve months ended March 31, 2025. The text explicitly states that the press release is furnished as an exhibit and that the information is not filed for purposes of Section 18 or incorporated by reference. The document is short (3406 characters) and primarily serves as a current report announcing the earnings release rather than containing the earnings data itself. According to the rules, initial announcements of quarterly or periodical financial results (key highlights only) are classified as Earnings Release (ER). Since this is a Form 8-K announcing the earnings release, it fits best under ER rather than a full Interim Report (IR) or Annual Report (10-K). FY 2025
2025-05-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.